Trump is off to a great start, so it’s disappointing to see his tariff policy muddying the waters of where the U.S. and world ...
HHS head Robert F. Kennedy Jr. has long been an opponent of pharma influence in government. U.S. lawmakers are asking whether ...
Senators question Pfizer's partnership with UpScriptHealth, citing potential anti-kickback concerns and risks of increased ...
Irish Examiner on MSN3h
Irish pharma firms confident despite Trump's threats but experts warn of turbulent timesDonald Trump wants to 'take back' the US component of Ireland's pharma sector which supports 50,000 jobs, generates exports ...
Early on Tuesday, dozens of corporate executives and others assembled at a Yale CEO Caucus not far from the White House just as news emerged that the Trump administration planned to potentially double ...
As health care costs continue to rise and the burden of chronic disease grows, data-driven insights will be essential in ...
It started with tariffs, but the trade war is quickly escalating beyond import taxes into a broader tit-for-tat battle.
The technology and commercialization office for UNMC and UNO detailed a record number of patents issued in its 2024 annual ...
Most medical devices in the United States come to market with limited clinical data, and device surveillance is viewed as a key way to keep patients safe. But the FDA’s system for collecting data and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback